First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations - Concepedia

Concepedia

Publication | Open Access

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations

DOI Full Paper Access

67

Citations

22

References

2023

Year

Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa, Kana Hashimoto, Yosuke Kawashima, Tomohiro Sakamoto, Hiroshi Wakui, Shuji Murakami, Kyoichi Okishio, Kenji Hayashihara,

Abstract

Japan Registry of Clinical Trials Identifier: jRCTs071200002.

References

	Year	Citations

Page 1